LOX was identified to be upregulated in breast cancer cells with metastatic ability and to facilitate breast cancer cell migration and adhesion through the hydrogen peroxide-mediated regulation of the FAK/Src signaling pathway leading to downstream changes in cell adhesion and migration (13,25). Here, PTK2 is linked to breast cancer.